UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The journal of pain, ISSN 1526-5900, 2008, Volume 9, Issue 12, pp. 1144 - 1154
Anesthesia & Perioperative Care | Pain Medicine | prolonged release | naloxone | bowel function | chronic pain | Oxycodone | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Narcotic Antagonists - administration & dosage | Humans | Male | Dose-Response Relationship, Drug | Analgesics, Opioid - adverse effects | Time Factors | Low Back Pain - psychology | Female | Oxycodone - adverse effects | Drug Therapy, Combination | Severity of Illness Index | Oxycodone - therapeutic use | Double-Blind Method | Drug Administration Schedule | Oxycodone - administration & dosage | Narcotic Antagonists - adverse effects | Analgesics, Opioid - therapeutic use | Naloxone - therapeutic use | Treatment Outcome | Constipation - chemically induced | Low Back Pain - drug therapy | Pain Measurement - methods | Narcotic Antagonists - therapeutic use | Analgesics, Opioid - administration & dosage | Naloxone - adverse effects | Naloxone - administration & dosage | Chronic Disease | Delayed-Action Preparations | Care and treatment | Naloxone | Pain | Backache | Analysis | Index Medicus
Journal Article
09/2019
Streaming Video
12/2018
Streaming Video
Addiction (Abingdon, England), ISSN 0965-2140, 05/2016, Volume 111, Issue 5, pp. 883 - 891
effectiveness | statistical power | Before/after policy evaluation | take‐home naloxone | national naloxone programme | prison release opioid‐related deaths | causality | opioid‐related deaths | Effectiveness | Prison release opioid-related deaths | Take-home naloxone | Causality | Statistical power | National naloxone programme | Opioid-related deaths | Life Sciences & Biomedicine | Substance Abuse | Psychiatry | Science & Technology | Analgesics, Opioid - economics | Humans | Middle Aged | Analgesics, Opioid - poisoning | Male | Naloxone - therapeutic use | Treatment Outcome | Scotland - epidemiology | Narcotic Antagonists - economics | Opioid-Related Disorders - rehabilitation | Opioid-Related Disorders - economics | Narcotic Antagonists - therapeutic use | Cost-Benefit Analysis | Opioid-Related Disorders - mortality | Adult | Female | Aged | Naloxone - economics | Prisoners | Analysis | Naloxone | Narcotics | Drug prevention | Drug addiction | Index Medicus | Before | after policy evaluation | Research Report | Research Reports
Journal Article
02/2018
Streaming Video
The European journal of neuroscience, ISSN 0953-816X, 07/2008, Volume 28, Issue 1, pp. 20 - 29
(+)‐naltrexone | stereoselectivity | (+)‐naloxone | microglia | Stereoselectivity | (+)-naltrexone | (+)-naloxone | Microglia | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Naltrexone - therapeutic use | Microglia - metabolism | Humans | Male | Pain - chemically induced | Pain - metabolism | Naltrexone - pharmacology | Narcotic Antagonists - metabolism | Pain - drug therapy | Behavior, Animal - drug effects | Toll-Like Receptor 4 - antagonists & inhibitors | Naltrexone - metabolism | Biomarkers - metabolism | Injections, Spinal | Cell Line | Naloxone - metabolism | Rats | Behavior, Animal - physiology | Naloxone - therapeutic use | Rats, Sprague-Dawley | Toll-Like Receptor 4 - metabolism | Animals | Narcotic Antagonists - therapeutic use | Signal Transduction - drug effects | Naloxone - pharmacology | Narcotic Antagonists - pharmacology | Signal Transduction - physiology | Pain Measurement | Naltrexone | Naloxone | Index Medicus
Journal Article
11/2017
Streaming Video
Drug and alcohol dependence, ISSN 0376-8716, 2014, Volume 148, pp. 62 - 68
Psychiatry | Treatment outcome | Prescription opioids | Behavioral economics | Buprenorphine–naloxone | Buprenorphine-naloxone | Life Sciences & Biomedicine | Substance Abuse | Science & Technology | Predictive Value of Tests | Opioid-Related Disorders - drug therapy | Humans | Middle Aged | Prescription Drug Misuse - economics | Male | Opiate Substitution Treatment - psychology | Adult | Female | Opiate Substitution Treatment - trends | Naloxone - economics | Buprenorphine, Naloxone Drug Combination - economics | Prescription Drug Misuse - trends | Opiate Substitution Treatment - economics | Economics, Behavioral - trends | Opioid-Related Disorders - psychology | Buprenorphine - economics | Naloxone - therapeutic use | Treatment Outcome | Narcotic Antagonists - economics | Opioid-Related Disorders - economics | Buprenorphine - therapeutic use | Narcotic Antagonists - therapeutic use | Prescription Drug Misuse - psychology | Buprenorphine, Naloxone Drug Combination - therapeutic use | Aged | Economic aspects | Drug abuse | Index Medicus
Journal Article
Drug and alcohol dependence, ISSN 0376-8716, 2013, Volume 131, Issue 1, pp. 119 - 126
Psychiatry | Opioid dependency | Buprenorphine–naloxone tablets | Randomised controlled trial | Buprenorphine–naloxone film | Opioid substitution therapy | Buprenorphine-naloxone tablets | Buprenorphine-naloxone film | Life Sciences & Biomedicine | Substance Abuse | Science & Technology | Opioid-Related Disorders - drug therapy | Administration, Sublingual | Double-Blind Method | Tablets | Buprenorphine - blood | Humans | Middle Aged | Male | Treatment Outcome | Opioid-Related Disorders - blood | Chemistry, Pharmaceutical | Naloxone - blood | Dose-Response Relationship, Drug | Buprenorphine - administration & dosage | Adult | Female | Disease Management | Naloxone - administration & dosage | Medical policy | Medical colleges | Drug abuse | Neurosciences | Naloxone | Buprenorphine | Public health | Index Medicus
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.